We also found that tumor infiltration of CD3+ T and CD8+ T cells, CCR5 expression, and T-cell activation in tumors were all significantly reduced after PCYT2 knockdown (Fig. 6i and j, Supplementary Fig. S6f and g). This evidence concerns the gene CCR5 and neoplasm.